Showing results (1121-1130 of 1,221) with videos related to

Sort By:
Pageof 123
Cancer Discovery|September 21, 2021
INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase InhibitorsQing Li, Baishan Jiang, Jiaye Guo, et al.
NPJ Precision Oncology|February 12, 2024
Genomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterationsHiginio Dopeso, Andrea M Gazzo, Fatemeh Derakhshan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2026
The Genomic Landscape of MYC, MYCL, and MYCN Amplified Solid TumorsMatteo Repetto, Allison L Richards, Monica F Chen, et al.
Science Translational Medicine|September 3, 2011
Identification of a disease-defining gene fusion in epithelioid hemangioendotheliomaMunir R Tanas, Andrea Sboner, Andre M Oliveira, et al.
Nature Genetics|May 16, 2025
APOBEC3 mutagenesis drives therapy resistance in breast cancerAvantika Gupta, Andrea Gazzo, Pier Selenica, et al.
Cancer Cell|September 5, 2020
FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast CancerAmaia Arruabarrena-Aristorena, Jesper L V Maag, Srushti Kittane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2022
Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical ProfilesBeryl L Manning-Geist, Ying L Liu, Kelly A Devereaux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2023
A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast CancerJamunarani Veeraraghavan, Carolina Gutierrez, Carmine De Angelis, et al.
Lancet (London, England)|December 17, 2023
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 studyChiaojung Jillian Tsai, Jonathan T Yang, Narek Shaverdian, et al.
Chemmedchem|April 30, 2024
Anticonvulsant activity of Tetrahydrolinalool: behavioral, electrophysiological, and molecular docking approachesDiogo V Fonsêca, Pablo R da Silva, Hugo F O Pires, et al.
Pageof 123